A detailed history of Allied Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Allied Investment Advisors, LLC holds 252 shares of LLY stock, worth $227,702. This represents 0.04% of its overall portfolio holdings.

Number of Shares
252
Previous 269 6.32%
Holding current value
$227,702
Previous $243,000 8.23%
% of portfolio
0.04%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$772.14 - $960.02 $13,126 - $16,320
-17 Reduced 6.32%
252 $223,000
Q1 2024

Apr 11, 2024

BUY
$592.2 - $792.28 $159,301 - $213,123
269 New
269 $209,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $859B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Allied Investment Advisors, LLC Portfolio

Follow Allied Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allied Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allied Investment Advisors, LLC with notifications on news.